PubRank

Rosanna Di Paola

Author PubWeight™ 137.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy. Free Radic Biol Med 2008 1.65
2 Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice. Intensive Care Med 2003 1.52
3 Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol 2004 1.50
4 Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res Ther 2013 1.49
5 Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 2004 1.48
6 Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice. Crit Care Med 2007 1.48
7 Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 2011 1.40
8 Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 2004 1.39
9 A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J Neuroinflammation 2013 1.34
10 The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol Pharmacol 2002 1.29
11 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorg Med Chem 2005 1.29
12 Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav Immun 2011 1.27
13 Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2005 1.25
14 A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 2002 1.23
15 Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest 2004 1.20
16 Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest 2004 1.17
17 A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock. J Pharmacol Exp Ther 2006 1.15
18 Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 2008 1.14
19 The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J Leukoc Biol 2006 1.13
20 Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 2008 1.12
21 Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB J 2005 1.11
22 Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol Res 2008 1.10
23 The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. Intensive Care Med 2005 1.10
24 Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J 2008 1.08
25 Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 2003 1.07
26 TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008 1.05
27 Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. J Immunol 2006 1.04
28 Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum 2003 1.04
29 Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin Immunol 2006 1.04
30 Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 2006 1.03
31 Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J Neurosurg Spine 2004 1.02
32 CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. Eur J Pharmacol 2011 1.01
33 Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 2003 1.01
34 Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. J Pharmacol Exp Ther 2008 1.01
35 Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir Res 2005 1.01
36 Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intensive Care Med 2007 1.00
37 Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol 2010 1.00
38 Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med 2004 0.98
39 Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein. Eur J Pharmacol 2006 0.98
40 Erythropoietin reduces the development of experimental inflammatory bowel disease. J Pharmacol Exp Ther 2004 0.98
41 Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids. Mol Pharmacol 2007 0.97
42 ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR alpha IN THE DEVELOPMENT OF BLEOMYCIN-INDUCED LUNG INJURY. Shock 2005 0.97
43 Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury. J Pharmacol Exp Ther 2010 0.97
44 Protective effect of Arbutus unedo aqueous extract in carrageenan-induced lung inflammation in mice. Pharmacol Res 2007 0.96
45 Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. Eur J Pharmacol 2002 0.96
46 Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock 2008 0.96
47 Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 2009 0.95
48 Protective effects of anthocyanins from blackberry in a rat model of acute lung inflammation. Free Radic Res 2003 0.94
49 Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury. Free Radic Biol Med 2007 0.94
50 Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock 2008 0.93
51 Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol Pharmacol 2004 0.93
52 Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury. Free Radic Res 2009 0.93
53 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration. Lab Invest 2005 0.92
54 Superoxide: a key player in hypertension. FASEB J 2004 0.92
55 Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. Eur J Pharmacol 2011 0.92
56 Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation. Br J Pharmacol 2004 0.91
57 MEK inhibition suppresses the development of lung fibrosis in the bleomycin model. Naunyn Schmiedebergs Arch Pharmacol 2011 0.91
58 Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease. CNS Neurol Disord Drug Targets 2015 0.91
59 Protective effect of orally administered carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2007 0.91
60 Increased oxidative-related mechanisms in the spinal cord injury in old rats. Neurosci Lett 2005 0.91
61 The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br J Pharmacol 2003 0.91
62 Anti-inflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice. Mediators Inflamm 2012 0.91
63 WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 2004 0.90
64 Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma. J Neurochem 2009 0.90
65 Peroxisome proliferator-activated receptor-alpha modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice. Shock 2009 0.90
66 The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy. Clin Nutr 2011 0.89
67 Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 2006 0.89
68 Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis. Intensive Care Med 2004 0.88
69 Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. J Leukoc Biol 2004 0.88
70 Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J Pineal Res 2007 0.88
71 Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock 2007 0.88
72 Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther 2008 0.87
73 Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol Immunotoxicol 2005 0.87
74 A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. FASEB J 2013 0.87
75 PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion. FASEB J 2005 0.87
76 Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J Pharmacol Exp Ther 2011 0.87
77 Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic. Shock 2004 0.87
78 Involvement of 5-lipoxygenase in spinal cord injury. J Neuroimmunol 2005 0.87
79 Effects of a polyphenol present in olive oil, oleuropein aglycone, in a murine model of intestinal ischemia/reperfusion injury. J Leukoc Biol 2012 0.87
80 Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 2005 0.87
81 Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit Care Med 2004 0.86
82 Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. J Pharmacol Exp Ther 2005 0.86
83 Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury. Shock 2009 0.86
84 Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 2003 0.86
85 Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury. J Pharmacol Exp Ther 2008 0.86
86 Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB J 2006 0.85
87 Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. Shock 2008 0.85
88 The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord. Shock 2009 0.85
89 Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies. J Neuroinflammation 2014 0.85
90 The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice. Biochem Pharmacol 2012 0.84
91 5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein. Immunology 2003 0.84
92 Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice. Shock 2009 0.84
93 Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury. J Leukoc Biol 2009 0.84
94 Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice. Shock 2007 0.83
95 Absence of endogenous interleukin-10 enhances the evolution of acute lung injury. Eur Cytokine Netw 2002 0.83
96 Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery 2005 0.82
97 Inhibition of ceramide biosynthesis ameliorates pathological consequences of spinal cord injury. Shock 2009 0.82
98 Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Med 2011 0.82
99 Calpain inhibitor I reduces intestinal ischemia-reperfusion injury in the rat. Shock 2004 0.82
100 GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat. Biochem Pharmacol 2002 0.82
101 Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. J Leukoc Biol 2004 0.82
102 Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein. Immunology 2006 0.82
103 Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects. Pharmacol Res 2009 0.82
104 Role of 5-lipoxygenase in the multiple organ failure induced by zymosan. Intensive Care Med 2004 0.82
105 N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury. Shock 2007 0.82
106 Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice. Free Radic Biol Med 2006 0.82
107 Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma. Naunyn Schmiedebergs Arch Pharmacol 2009 0.82
108 Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-{gamma}. J Leukoc Biol 2005 0.82
109 Effect of methylguanidine in a model of septic shock induced by LPS. Free Radic Res 2004 0.82
110 Increased carrageenan-induced acute lung inflammation in old rats. Immunology 2005 0.81
111 Protective effect of melatonin against the inflammatory response elicited by crude venom from isolated nematocysts of Pelagia noctiluca (Cnidaria, Scyphozoa). J Pineal Res 2009 0.81
112 5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan. J Leukoc Biol 2003 0.81
113 Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J Pharmacol Exp Ther 2006 0.81
114 PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol. J Pharmacol Exp Ther 2009 0.81
115 Exogenous T3 administration provides neuroprotection in a murine model of traumatic brain injury. Pharmacol Res 2013 0.81
116 Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock 2006 0.81
117 Effects of verbascoside biotechnologically produced by Syringa vulgaris plant cell cultures in a rodent model of colitis. Naunyn Schmiedebergs Arch Pharmacol 2009 0.80
118 Neuroprotection and enhanced recovery with hypericum perforatum extract after experimental spinal cord injury in mice. Shock 2006 0.80
119 PPAR-alpha modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma. Pharmacol Res 2009 0.80
120 EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney. Am J Nephrol 2004 0.80
121 Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2011 0.80
122 Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. Shock 2009 0.80
123 Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis. Pancreas 2009 0.80
124 Effects of mitogen-activated protein kinase signaling pathway inhibition on the development of cerulein-induced acute pancreatitis in mice. Pancreas 2012 0.80
125 Melatonin prevents lipopolysaccharide-induced hyporeactivity in rat. J Pineal Res 2004 0.80
126 Thalidomide treatment reduces colon injury induced by experimental colitis. Shock 2005 0.80
127 Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation. Int Immunopharmacol 2007 0.80
128 Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut. Naunyn Schmiedebergs Arch Pharmacol 2005 0.79
129 Melatonin limits lung injury in bleomycin treated mice. J Pineal Res 2005 0.79
130 Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. Cytokine 2007 0.79
131 Role of endogenous glutathione in the secondary damage in experimental spinal cord injury in mice. Neurosci Lett 2007 0.79
132 High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis. Shock 2004 0.79
133 GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan. Shock 2011 0.79
134 Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice. Shock 2009 0.79
135 Erythropoietin suppresses peritoneal fibrosis in rat experimental model. Eur J Pharmacol 2008 0.78
136 Effect of anthocyanins contained in a blackberry extract on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Planta Med 2004 0.78
137 Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice. Free Radic Res 2011 0.78
138 Efficacy of treatment with verbascoside, biotechnologically produced by Syringa vulgaris plant cell cultures in an experimental mice model of spinal cord trauma. Naunyn Schmiedebergs Arch Pharmacol 2010 0.78
139 Effect of thalidomide on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock 2008 0.78
140 5-lipoxygenase knockout mice exhibit a resistance to splanchnic artery occlusion shock. Shock 2003 0.78
141 Effect of pyrimethamine in experimental rheumatoid arthritis. Med Sci Monit 2005 0.77
142 Hypericum perforatum attenuates the development of carrageenan-induced lung injury in mice. Free Radic Biol Med 2005 0.77
143 Effect of methylguanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol 2004 0.77
144 WY-14643, a Potent Peroxisome Proliferator Activator Receptor-α PPAR-α Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis. PPAR Res 2010 0.77
145 Methylguanidine reduces the development of non septic shock induced by zymosan in mice. Life Sci 2004 0.76
146 Fluridone as a new anti-inflammatory drug. Eur J Pharmacol 2013 0.76
147 Pyrrolidine dithiocarbamate reduced experimental periodontitis. Eur J Pharmacol 2006 0.76
148 Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome. Shock 2008 0.76
149 Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock. Crit Care Med 2004 0.75
150 Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice. Pharmacol Res 2010 0.75
151 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn Schmiedebergs Arch Pharmacol 2004 0.75
152 Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma. Neuropharmacology 2007 0.75